Beyond this, Novo Nordisk and Eli Lilly have patents and lots and lots of lawyers, so it will be interesting to see how enduring a program like HIMS will be
In this study it was used to determine insulin resistance in women with PCOS
When gut bacteria break down soluble fiber and resistant starch, they produce short-chain fatty acids that may interact with receptors on L-cells involved in hormone signaling
Reading the adjunct evidence the way a reviewer would The pivotal liraglutide trials, ADJUNCT ONE and TWO, showed HbA1c effects below the regulatory threshold alongside dose-related ketosis and symptomatic hypoglycaemia, and the FDA did not approve liraglutide for type 1 on efficacy and safety grounds.6 The newer story is the automated-insulin-delivery era: ADJUST-T1D paired weekly semaglutide with an AID system in 72 adults with type 1 and obesity, and a composite goal (time in range above 70%, time below range under 4%, and at least 5% weight loss) was met by 36% versus 0% on placebo, with no ketoacidosis.8 Tirzepatide in type 1 rests on a single-centre observational cohort of 26 with no control arm
Medication selection depends on medical history, safety factors, diagnosis, medication availability, insurance rules, and provider judgment
This can be a game-changer to help you get through the adjustment period comfortably
